Resultados da pesquisa - Kees Brinkman

Refinar resultados
  1. 1
    Management of hyperlactatemia: no need for routine lactate measurements

    Management of hyperlactatemia: no need for routine lactate measurements Por Kees Brinkman

    Publicado em 2001
    Obter o texto integral
    Carta
    Adic. favoritos
    Na minha lista:
  2. 2
    Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals

    Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals Por Ard van Sighem, Luuk Gras, Peter Reiss, Kees Brinkman, Frank de Wolf

    Publicado em 2010
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  3. 3
    The effects of autonomous sensory meridian response (ASMR) on mood, attention, heart rate, skin conductance and EEG in healthy young adults

    The effects of autonomous sensory meridian response (ASMR) on mood, attention, heart rate, skin conductance and EEG in healthy young adults Por Hessel Engelbregt, Kees Brinkman, C. C. E. van Geest, M. Irrmischer, J.B. Deijen

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    Adverse effects of reverse transcriptase inhibitors

    Adverse effects of reverse transcriptase inhibitors Por Kees Brinkman, Hadewych J. M. ter Hofstede, David M. Burger, Jan Smeitink, Peter P. Koopmans

    Publicado em 1998
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  5. 5
    <i>Aspergillus</i> Meningitis: Diagnosis by Non-Culture-Based Microbiological Methods and Management

    <i>Aspergillus</i> Meningitis: Diagnosis by Non-Culture-Based Microbiological Methods and Management Por Paul E. Verweij, Kees Brinkman, Herbert P. H. Kremer, Bart Jan Kullberg, Jacques F. Meis

    Publicado em 1999
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    Future challenges for clinical care of an ageing population infected with HIV: a modelling study

    Future challenges for clinical care of an ageing population infected with HIV: a modelling study Por Mikaëla Smit, Kees Brinkman, Suzanne E. Geerlings, Colette Smit, Kalyani Thyagarajan, Ard van Sighem, Frank de Wolf, Timothy B. Hallett

    Publicado em 2015
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Carbamazepine–Indinavir Interaction Causes Antiretroviral Therapy Failure

    Carbamazepine–Indinavir Interaction Causes Antiretroviral Therapy Failure Por Patricia W. H. Hugen, David M. Burger, Kees Brinkman, Hadewych JM ter Hofstede, Rob Schuurman, Peter P. Koopmans, Yechiel A. Hekster

    Publicado em 2000
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy

    HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy Por Radjin Steingrover, Katalyn Pogány, E. Fernández García, Suzanne Jurriaans, Kees Brinkman, Hanneke Schuitemaker, Frank Miedema, Joep MA Lange, Jan M. Prins

    Publicado em 2008
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM

    Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM Por Femke A.E. Lambers, Maria Prins, Xiomara V. Thomas, Richard Molenkamp, David Kwa, Kees Brinkman, Jan T. M. van der Meer, Janke Schinkel

    Publicado em 2011
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  10. 10
    Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996–2014: results from a national observational cohort

    Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996–2014: results from a national observational cohort Por Eline Op de Coul, Ard van Sighem, Kees Brinkman, Birgit HB van Benthem, Marc van der Valk, Suzanne E. Geerlings, Peter Reiss

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    Discontinuation of Nevirapine Because of Hypersensitivity Reactions in Patients with Prior Treatment Experience, Compared with Treatment-Naive Patients: The ATHENA Cohort Study

    Discontinuation of Nevirapine Because of Hypersensitivity Reactions in Patients with Prior Treatment Experience, Compared with Treatment-Naive Patients: The ATHENA Cohort Study Por F. W. N. M. Wit, A Kesselring, Luuk Gras, Clemens Richter, Marc van der Valk, Kees Brinkman, J Lange, Florian Wolf, Peter Reiss

    Publicado em 2008
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  12. 12
    First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir

    First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir Por Marit GA van Vonderen, Paul Lips, Michiel A. van Agtmael, Elly A. Hassink, Kees Brinkman, Suzanne E. Geerlings, Jussi Sutinen, Matti Ristola, Sven A. Danner, Peter Reiss

    Publicado em 2009
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    Impact of Switching From Zidovudine to Tenofovir Disoproxil Fumarate on Bone Mineral Density and Markers of Bone Metabolism in Virologically Suppressed HIV-1 Infected Patients; A Substudy of the PREPARE Study

    Impact of Switching From Zidovudine to Tenofovir Disoproxil Fumarate on Bone Mineral Density and Markers of Bone Metabolism in Virologically Suppressed HIV-1 Infected Patients; A S... Por Aoife G. Cotter, S.M.E. Vrouenraets, Jennifer J. Brady, Ferdinand W.N.M. Wit, Christoph A. Fux, Hansjakob Furrer, Kees Brinkman, Caroline Sabin, Peter Reiss, Patrick Mallon

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  14. 14
    Mortality and progression to AIDS after starting highly active antiretroviral therapy

    Mortality and progression to AIDS after starting highly active antiretroviral therapy Por Ard I. van Sighem, Mark A. van de Wiel, Azra C. Ghani, Mariëlle Jambroes, Peter Reiss, Inge C. Gyssens, Kees Brinkman, Joep M. A. Lange, Frank de Wolf

    Publicado em 2003
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  15. 15
    Health-related quality of life of people with HIV

    Health-related quality of life of people with HIV Por Esther A. N. Engelhard, Colette Smit, Peter R. van Dijk, T. Martijn Kuijper, Paulien R. Wermeling, A. Weel, Michiel R. de Boer, Kees Brinkman, Suzanne E. Geerlings, Pythia T. Nieuwkerk

    Publicado em 2017
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  16. 16
    Protective effect of hepatitis B virus-active antiretroviral therapy against primary hepatitis B virus infection

    Protective effect of hepatitis B virus-active antiretroviral therapy against primary hepatitis B virus infection Por Merel M. Heuft, Sanne M. Houba, Guido E.L. van den Berk, Tessa Smissaert van de Haere, Alje P. van Dam, Lea M. Dijksman, Rosa M. Regez, Kees Brinkman

    Publicado em 2014
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  17. 17
    Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA Cohort

    Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA Cohort Por Jeanne P. Dieleman, Mariëlle Jambroes, Inge C. Gyssens, Miriam Sturkenboom, Bruno H. Stricker, W. Mulder, Frank de Wolf, Gerrit‐Jan Weverling, Joep M. A. Lange, Peter Reiss, Kees Brinkman

    Publicado em 2002
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  18. 18
    Zidovudine/Lamivudine for HIV-1 Infection Contributes to Limb Fat Loss

    Zidovudine/Lamivudine for HIV-1 Infection Contributes to Limb Fat Loss Por Marit G. A. van Vonderen, Michiel A. van Agtmael, Elly A. Hassink, Ana Milinkovic, Kees Brinkman, Suzanne E. Geerlings, Matti Ristola, Arne van Eeden, Sven A. Danner, Peter Reiss

    Publicado em 2009
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  19. 19
    No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial

    No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial Por Marlous L. Grijsen, Radjin Steingrover, Ferdinand W N M Wit, Suzanne Jurriaans, Annelies Verbon, Kees Brinkman, Marc van der Valk, Robin Soetekouw, Frank de Wolf, Joep M. A. Lange, Hanneke Schuitemaker, Jan M. Prins

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  20. 20
    Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals

    Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals Por David M. Burger, Patricia W. H. Hugen, Peter Reiss, Inge C. Gyssens, M. M. E. Schneider, Frank P. Kroon, Gerrit Schreij, Kees Brinkman, Clemens Richter, Jan M. Prins, Rob E. Aarnoutse, Joep M. A. Lange

    Publicado em 2003
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: